DHR
NYSE
US
Danaher Corporation Common Stock
$195,06
▼ $-3,08
(-1,55%)
Vol. 326K
Cap. mercato
$134.1B
P/E
37,1
ROE
7,0%
Margine
14,7%
Beta
0,92
Rendimento div.
0,83%
52W
$171–$243
Consenso Wall Street
30 analisti · Apr 202611
Acquisto forte
15
Compra
4
Mantieni
0
Vendi
0
Vendita forte
86,7%
Rating Compra
Grafico dei Prezzi
Titoli simili
TMO
Thermo Fisher Scientific Inc
P/E 27,5
$184.3B
A
Agilent Technologies Inc
P/E 25,2
$32.5B
WAT
Waters Corp
P/E 48,9
$31.4B
IQV
IQVIA Holdings Inc
P/E 20,9
$28.4B
MTD
Mettler-Toledo International Inc
P/E 31,0
$26.9B
ILMN
Illumina Inc
P/E 28,5
$20.0B
WST
West Pharmaceutical Services Inc
P/E 37,7
$18.6B
MEDP
Medpace Holdings Inc
P/E 36,5
$15.8B
TEM
Tempus AI Inc
$10.5B
RVTY
Revvity Inc
P/E 41,6
$10.0B
Utili
Tasso di battuta: 100,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $2,17 | $2,23 | +$0,06 |
| Set 2025 | $1,74 | $1,89 | +$0,15 |
| Giu 2025 | $1,66 | $1,80 | +$0,14 |
| Mar 2025 | $1,66 | $1,88 | +$0,22 |
Ricavi e utili trimestrali
| Trimestre | 2024-0… | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|---|
| Ricavi | — | $6.5B | $5.7B | $5.9B | $6.1B | $6.8B |
| Utile netto | — | $1.1B | $954.0M | $555.0M | $908.0M | $1.2B |
Rapporti chiave
ROA (TTM)
4,5%
P/S (TTM)
5,46
P/B
3,1
EPS (TTM)
$5,05
CF/Share
$10,94
Crescita ricavi 3A
-2,7%
52W High
$242,80
52W Low
$171,00
$171,00
Intervallo 52 settimane
$242,80
Salute finanziaria
Flusso di cassa libero
$1.7B
Debito netto
$15.1B
Liquidità
$4.6B
Debito totale
$19.7B
Aggiornato al Dic 31, 2025
Як DHR виглядає на тлі конкурентів у Life Sciences Tools & Services?
Група порівняння: Peers · Life Sciences Tools & Services (Peers) · 10 компаній
Оцінка DHR vs аналоги Life Sciences Tools & Services
P/E
37,1
▲
20%
sopra
peer
(31,0)
vs Peer
vs Settore
Sopravvalutato
P/S
5,5
▼
5%
sotto
peer
(5,8)
vs Peer
vs Settore
Valore equo
P/B
3,1
▼
59%
sotto
peer
(7,5)
vs Peer
vs Settore
Sottovalutato
Дивідендна дохідність
0,8%
▲
38%
sopra
peer
(0,6%)
vs Peer
vs Settore
Rendimento basso
Прибутковість DHR vs аналоги Life Sciences Tools & Services
ROE
7,0%
▼
67%
sotto
peer
(21,0%)
vs Peer
vs Settore
Debole
Net margin
14,7%
▼
9%
sotto
peer
(16,2%)
vs Peer
vs Settore
Debole
Валова маржа
59,2%
▲
6%
sopra
peer
(55,9%)
vs Peer
vs Settore
In linea
ROA
4,5%
▼
59%
sotto
peer
(10,9%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя DHR vs аналоги Life Sciences Tools & Services
D/E ratio
—
▼
0%
sotto
peer
(83,7)
vs Peer
vs Settore
In linea
Поточна ліквідність
1,9
▲
4%
sopra
peer
(1,8)
vs Peer
vs Settore
In linea
Beta
0,9
▼
30%
sotto
peer
(1,3)
vs Peer
vs Settore
Più volatile
Радар фундаменталів DHR
DHR
Mediana peer
Industria
DHR прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
DHR vs аналоги: ключові метрики
Attività insider
BearishAcquisti
17
Vendite
1
$274575
RALES MITCHELL P
Officer and Director · Feb 27
gift
71648 shs
GRAY ROBERT BRADLEY
Officer · Feb 27
award
2849 shs
LEIKEN JONATHAN B
Officer · Feb 27
award
2374 shs
BLAIR RAINER M
Chief Executive Officer · Feb 27
award
17566 shs
GUTIERREZ-RAMOS JOSE-CARLOS
Officer · Feb 27
award
6647 shs
MCGREW MATTHEW
Officer · Feb 27
award
5935 shs
BOUDA CHRISTOPHER
Officer · Feb 27
award
1247 shs
COUCHARA GEORGEANN F.
Officer · Feb 27
award
4748 shs
RILEY CHRISTOPHER PAUL
Officer · Feb 27
award
6172 shs
SAWYER MONTGOMERY JULIE A
Officer · Feb 27
award
6172 shs
Ultimo 90 giorni
Principali azionisti
Top 5: 25,69%Vanguard Group Inc
8,62%
$11.6B
Blackrock Inc.
7,35%
$9.9B
State Street Corporation
3,91%
$5.2B
JPMORGAN CHASE & CO
3,05%
$4.1B
FMR, LLC
2,76%
$3.7B
Aggiornato al Dic 31, 2025
Dividendi
$1,36
/ anno
Mar 27, 2026
$0,4000
Dic 26, 2025
$0,3200
Set 26, 2025
$0,3200
Giu 27, 2025
$0,3200
Mar 28, 2025
$0,3200
Dic 27, 2024
$0,2700
Set 27, 2024
$0,2700
Giu 28, 2024
$0,2700